Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Prothena
Prothena
The Best Biotech Stocks in 2015
Motley Fool
Mon, 12/28/15 - 09:58 am
Eagle Pharmaceuticals
Exelixis
Prothena
3 Rising Biotechs That Should Continue Their Upward Trends
TheStreet.com
Sat, 12/12/15 - 01:58 pm
biotech
Intra-Cellular Therapies
Anacor
Prothena
3 Long Shots Biotech Companies Are Working On
Motley Fool
Sat, 07/11/15 - 10:27 am
biotech
Alzheimer's disease
Parkinson's Disease
Axovant Sciences
RVT 101
GSK
Biogen
aducanumab
Prothena
PRX-002
3 Little-Known Biotechs Working On Potential Blockbusters
Motley Fool
Sun, 03/29/15 - 11:42 am
Ophthotech
Fovista
Esperion Therapeutics. ETC-1002
Prothena
PRX-002
This Tiny Biotech Offers Up New Hope for Parkinson's Disease Patients
Motley Fool
Wed, 03/25/15 - 08:55 am
Prothena
Parkinson's Disease
Prothena rockets up with early data on a Roche-partnered Parkinson's drug
Fierce Biotech
Fri, 03/20/15 - 08:24 am
Roche
Prothena
PRX002
Parkinson's Disease
3 Biotech Stocks Falling Like a Knife: Aegerion, Insys, and Prothena
Motley Fool
Tue, 05/27/14 - 09:51 pm
Aegerion
Insys
Prothena
Today’s Top Biotech Stories: Horizon Pharma, Prothena, and Portola Pharmaceuticals
Motley Fool
Wed, 03/19/14 - 12:01 pm
Horizon Pharma
Prothena
Portola Pharmaceuticals
M&A
Vidara
NEOD001
andexanet alfa
The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28
Forbes
Mon, 03/3/14 - 08:12 am
InterMune
Prana Biotechnology
Cara Therapeutics
Prothena
Endologix
Ampio Pharmaceuticals
Questcor Pharmaceuticals
Aegerion
3 Big-Volume Biotech Stocks to Watch
TheStreet.com
Thu, 01/30/14 - 10:06 am
biotech
Questcor
Auxilium
Prothena
3 Companies Working on Parkinson's Treatments You Ought to Know About
Motley Fool
Wed, 01/29/14 - 05:42 pm
Parkinson's Disease
Chelsea Therapeutics
Prothena
Avanir
AVP-923
Northera
PRX-002
Roche in deal worth up to $600 mln for Prothena Parkinson's drug
Yahoo/Reuters
Thu, 12/12/13 - 11:13 am
Roche
Prothena
Parkinson's Disease
PRX-022
Pages
« first
‹ previous
1
2